HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, today announced ...
Pulse Biosciences’ nPulse™ Technology to be Featured at the Heart Rhythm Society 2026 Annual Meeting
Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse™ technology using proprietary nanosecond pulsed field ablation™ (nsPFA™) energy, today announced that its nPulse™ Cardiac Catheter will be ...
WENZHOU, ZHEJIANG, CHINA, April 3, 2026 /EINPresswire.com/ — Imagine welding paper-thin stainless steel without a trace of distortion, or perfectly fusing joints ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results